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Abstract
Alzheimer’s Disease (AD), is a progressive neurodegenerative disease that is fatal. Amyloid
? (A?) aggregates are produced in the relation between AD and its later stages. While AD is not
necessarily present because of the A? aggregates, they are however a cohesive sublimate of each
other within the later stages of the disease. Currently there are no drug preventative measures
that have been successful in bringing treatment to the A? aggregates. It has been shown that AD
had been most closely associated with the production of A? aggregates in relation to the progres-
sion of the disease. However, in regards to the lack of preventative measures in A? aggregates it
is suggested that reactive oxygen species (ROS) should be taken into consideration when taking
drug related measures. Specifically speaking it has been found that ROS levels are significantly
higher in brains with AD than in brains that are healthy. Taking into consideration both the ROS
levels, as well as the A? aggregates, it can be beneficial in detecting AD early on in order to take
preventative measures.
CRANAD-X is a family of curcumin analogue molecules which have previously been used in
NIRF (Near Infra-Red Fluorescence spectroscopy) imaging. This study is to show the computa-
tional values of each prospective system for an experimental value such as excitation, emission,
and wavelength emission. Experimental values found in this computational study will help to
further a close approximation to other molecules that are similar in structure in other experimen-
tal investigations. Similar molecules found in this study could be used for probes to detect A?
aggregates, and ROS levels.
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ABSTRACT 
Alzheimer's Disease (AD), is a progressive neurodegenerative disease that is fatal.  
Amyloid β (Aβ) aggregates are produced in the relation between AD and its later stages. While 
AD is not necessarily present because of the Aβ aggregates, they are however a cohesive sublimate 
of each other within the later stages of the disease. Currently there are no drug preventative 
measures that have been successful in bringing treatment to the Aβ aggregates. It has been shown 
that AD had been most closely associated with the production of Aβ aggregates in relation to the 
progression of the disease. However, in regards to the lack of preventative measures in Aβ 
aggregates it is suggested that reactive oxygen species (ROS) should be taken into consideration 
when taking drug related measures. Specifically speaking it has been found that ROS levels are 
significantly higher in brains with AD than in brains that are healthy.  Taking into consideration 
both the ROS levels, as well as the Aβ aggregates, it can be beneficial in detecting AD early on in 
order to take preventative measures.  
CRANAD-X is a family of curcumin analogue molecules which have previously been used 
in NIRF (Near Infra-Red Fluorescence spectroscopy) imaging. This study is to show the computa-
tional values of each prospective system for an experimental value such as excitation, emission, 
and wavelength emission. Experimental values found in this computational study will help to 
further a close approximation to other molecules that are similar in structure in other experimental 
investigations. Similar molecules found in this study could be used for probes to detect Aβ 
aggregates, and ROS levels. 
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